Crossmark

Exosome-disrupting peptides for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41563-023-01525-0

Published Online: 2023-03-29

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gong, Ningqiang https://orcid.org/0000-0002-9444-8505
Hamilton, Alex G. https://orcid.org/0000-0002-9810-5630
Mitchell, Michael J. https://orcid.org/0000-0002-3628-2244
License Information

Text and Data Mining valid from 2023-03-29

Version of Record valid from 2023-03-29
More Information

Article History

First Online: 29 March 2023

Competing interests

: The authors declare no competing interests.